( )
| Date | Reference |
|---|---|
| November 2011 |
Burden CS et al (2011): A monolith purification process for virus-like particles from yeast homogenate. Journal of Chromatography B, doi:10.1016/j.jchromb.2011.10.044 |
| November 2011 |
Hermann RJ et al (2011): Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry. Journal of Immunological Methods, doi:10.1016/j.jim.2011.10.009 |
| October 2011 |
Weinberg A et al (2011): Science gone translational: the OX40 agonist story. Immunological Reviews 244/1: 218-231 |
| August 2011 |
de Lau W et al (2011): Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476/293, doi:10.1038/ nature10337 |
| June 2011 |
van Montfort T et al (2011): A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses. JBC, 286, 22250-22261 |
| May 2011 |
Niessner C et al (2011): Avian Ultraviolet/Violet Cones Identified as Probable Magnetoreceptors. PLoS One. 2011; 6(5): e20091. |
| April 2011 |
Brancaleone V et al (2011): Evidence for an Anti-Inflammatory Loop Centered on Polymorphonuclear Leukocyte Formyl Peptide Receptor 2/Lipoxin A4 Receptor and Operative in the Inflamed Microvasculature. JImmunol 186/8, 4905-4914 |
| April 2011 |
Zaremba A, Schmuecker U and Esche H (2011): Sprouty is a cytoplasmic target of adenoviral E1A oncoproteins to regulate the receptor tyrosine kinase signalling pathway.Virology Journal 2011, 8:192 |
| March 2011 |
Porotto M et al (2011): Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus. PLoS One. 2011; 6(3): e16874. |
| January 2011 |
Kuespert K et al (2011): Neisseria meningitidis has two independent modes of recognizing its human receptor CEACAM1. PLoS One. 2011; 6(1): e14609. |
| December 2010 |
Hutchings CJ et al (2010): Therapeutic antibodies directed at G protein-coupled receptors. mAbs 2/6, 594-606. |
| December 2010 |
Legrand F et al (2010): Human Eosinophils Exert TNF-α and Granzyme A-Mediated Tumoricidal Activity toward Colon Carcinoma Cells. JImmunol 185/12, 7443-7451 |
| November 2010 |
Zeisel M et al (2010): Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. J Hepatol, doi:10.1016/j.jhep.2010.10.014 |
| November 2010 |
De Santo C et al (2010): Invariant NKT cells modulate the suppressive activity of Serum Amyloid A-differentiated IL-10-secreting neutrophils. Nat Immunol.; 11(11): 1039–1046. |
| October 2010 |
Spurr L et al (2010): Comparative analysis of Annexin A1-formyl peptide receptor 2/ALX expression in human leukocyte subsets. International Immunopharmacology, doi:10.1016/j.intimp.2010.10.006 |
| October 2010 |
Rolhion N et al (2010): Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut, 59/10: 1355-6 |
| October 2010 |
Weibel R et al (2010): Development of Standard Test Procedures for Quantifying Carry Over from Fixed Pipetting Tips in Liquid-Handling Systems. J Ass Lab Auto, 15/5: 369-378 |
| October 2010 |
Iten M et al (2010): Reduction of Carry Over in Liquid-Handling Systems With a Decontamination Step Integrated in the Washing Procedure. J Ass Lab Auto, 15/5: 379-389 |
| September 2010 |
Xianfeng Chen, Angela Shaulov Kask, et al (2010) Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays, Journal of Controlled Release, Volume 148, Issue 3, 20 December 2010, Pages 327-333, ISSN 0168-3659, DOI: 10.1016/j.jconrel.2010.09.001. |
| September 2010 |
VanDuijn M et al (2010): Immune Responses Are Characterized by Specific Shared Immunoglobulin Peptides That Can Be Detected by Proteomic Techniques. JBC 285, 29247-29253. |
| September 2010 |
Fofana I et al (2010): Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes. Gastoenterology (10.1053/j.gastro.2010.05.073). |
| September 2010 |
Angela Shaulov Kask, Xianfeng Chen, et al (2010): DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge, Vaccine, Volume 28, Issue 47, 3 November 2010, Pages 7483-7491, ISSN 0264-410X, DOI: 10.1016/j.vaccine.2010.09.014. |
| August 2010 |
Kanderova V et al (2010): Aberrantly expressed CEACAM6 is involved in the signaling leading to apoptosis of acute lymphoblastic leukemia cells. Exp Hem 38/8, 653-660. |
| July 2010 |
Ha CT et al (2010): Human Pregnancy Specific Beta-1-Glycoprotein 1 (PSG1) Has a Potential Role in Placental Vascular Morphogenesis. Biol Reprod.; 83(1): 27–35 |
| June 2010 |
Ortner E et al (2010): Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events. Blood 115/24, 5089-5096 |
| April 2010 |
Krieger SE et al (2010): Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associates. Hepatology, 51/4:1144-57 |
| April 2010 |
Betts AM et al (2010): The Application of Target Information and Preclinical Pharmacokinetic/Pharmacodynamic Modeling in Predicting Clinical Doses of a Dickkopf-1 Antibody for Osteoporosis. JPet, 333/1, 2-13 |
| March 2010 |
Abrami L et al (2010): Endocytosis of the Anthrax toxin is mediated by Clathrin, Actin and unconventional adaptors. PLoS Pathog. 2010 March; 6(3): e1000792. |
| January 2010 |
Singer B et al (2010): Deregulation of the CEACAM Expression Pattern Causes Undifferentiated Cell Growth in Human Lung Adenocarcinoma Cells. PLoS One. 2010; 5(1): e8747 |
| September 2009 |
Carvalho, FA et al (2009): Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. JEM, 206/10: 2179-2189. |
| August 2009 |
Gross JC et al (2009): E-cadherin Surface Levels in Epithelial Growth Factor-stimulated Cells Depend on Adherens Junction Protein Shrew-1. MBoC 20/15: 3598-3607 |
| July 2009 |
Yue T et al (2009): The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Mol Cell Proteomics. 8(7): 1697-707. |
| July 2009 |
Bratke et al (2009): Interleukin-4 suppresses the cytotoxic potential of in vitro generated, adaptive regulatory CD4+ T cells by down-regulation of granzyme B. Immunology. 127/3: 338–344 |
| July 2009 |
Adler H et al (2009): Perturbation of lytic and latent gammaherpesvirus infection in the absence of the inhibitory receptor CEACAM1. PLoS ONE 4/7 |
| May 2009 |
Porotto M et al (2009): Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy. J Virol., 83(10): 5148-55. |
| May 2009 |
Martins V et al (2009): ATLa, an Aspirin-Triggered Lipoxin A4 Synthetic Analog, Prevents the Inflammatory and Fibrotic Effects of Bleomycin-Induced Pulmonary Fibrosis. J Immunol, 182: 5374 -5381 |
| May 2009 |
Kang H et al (2009): Transfection of insulin-secreting cell line and rat islets by functional polymeric gene vector. Biomaterials, 30/14: 2837-2845 |
| March 2009 |
Taori V et al (2009): DNA delivery in vitro via surface release from multilayer assemblies with poly(glycoamidoamine)s. Acta Biomaterialia, 5/3: 925-933 |
| March 2009 |
Han Y et al (2009): Using DNA as drug-bioprocessing and delivery strategies. Chemical Engineering Research and Design, 87/3: 343-348 |
| March 2009 |
Latulippe D et al (2009): Elongational flow model for transmission of supercoiled plasmid DNA during membrane ultrafiltration. Journal of Membrane Science, 329/1: 201-208 |
| February 2009 |
Teijeiro-Osorio D et al (2009): Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. Eur J Pharm Biopharm, 71/2: 257-263 |
| February 2009 |
Srinivasachari S et al (2009): Versatile supramolecular pDNA vehicles via "click polymerization" of beta-cyclodextrin with oligoethyleneamines. Biomaterials, 30/5: 928-938 |
| February 2009 |
Semiramoth N et al (2009): Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase -and MAPK- dependent mechanism. J Leukocyte Biol, 85, 1-12 |
| January 2009 |
Guignot J et al. (2009): Human decay-accelerating factor and CEACAM receptor-mediated internalization and intracellular lifestyle of Afa/Dr diffusely adhering escherichia coli in epithelial cells. Infection and Immunity, 77/1, 517-531 |
| December 2008 |
Polymenidou M et al. (2008): The POM Monoclonals: A comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS ONE ; 3/12: e3872. |
| December 2008 |
Porada CD et al (2008): Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells. Exp Hematol, 36/12: 1739-1749 |
| November 2008 |
Hooper JW, et al (2008): Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus. FJ Virol., 82(3):1332-8. |
| November 2008 |
Beaslas O et al (2008): Transcriptome response of enterocytes to dietary lipids: impact on cell architecture, signaling, and metabolism genes. Am J Physiol Gastrointest Liver Physiol, 295/5: G942-52 |
| July 2008 |
Paulmann D et al. (2008): Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation. J Gen Virol 89, 1593-1604 |
| June 2008 |
Thomas SN et al. (2008): Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem, 283: 15647-55. |
| June 2008 |
Planaguama A et al (2008): Airway Lipoxin A4 Generation and Lipoxin A4 Receptor Expression Are Decreased in Severe Asthma. Am J Respir Crit Care Med, 178a: 574-582 |
| May 2008 |
Lee HSW et al (2008): CEACAM1 Dynamics during Neisseria gonorrhoeae Suppression of CD4+ T Lymphocyte Activation. J Immunol, 180: 6827-6835 |
| February 2008 |
Dalley D et al (2008): Development and evaluation of a gamma-interferon assay for tuberculosis in badgers (Meles meles). Tuberculosis 88/3: 235-243, doi:10.1016/j.tube.2007.11.001 |
| February 2008 |
Björkman L et al (2008): Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. J Leukoc Biol, 83: 245-53 |
| December 2007 |
Yoon J et al (2007): CD66b regulates adhesion and activation of human eosinophils. J Immunol, 179: 8454-62 |
| December 2007 |
Zeisel M et al. (2007): Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology, 46/6:1722-31 |
| December 2007 |
Riesenberg R et al (2007): Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma. Clin Cancer Res, 13/23, 6993-7002 |
| December 2007 |
Kilic N et al (2007): Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood, 110/13, 4223-4233 |
| August 2007 |
Schmitter T et al (2007): Opa proteins of pathogenic neisseriae initiate Src kinase-dependent or lipid raft-mediated uptake via distinct human carcinoembryonic antigen-related cell adhesion molecule isoforms. Infect Immun, 75/8:4116-26. |
| June 2007 |
Bonn S et al (2007): Combinatorial expression of α- and γ-protocadherins alters their presenilin-dependent processing. Mol Cell Biol, 27/11: 4121-4132 |
| May 2007 |
Morris NP et al (2007): Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain. Mol Immunol 44/12: 3112-3121 |
| May 2007 |
Catanese MT et al. (2007): High avidity monoclonal antibodies against human scavenger receptor class B type I efficiently block hepatitis C virus infection in the presence of HDL. J Virol, 2007 0: JVI.00193-07 |
| April 2007 |
Schreiner A et al. (2007): Junction protein Shrew-1 influences cell invasion and interacts with invasion-promoting protein CD147. Mol Biol Cell, 18/4:1272-81 |
| March 2007 |
Vicovac L et al (2007):Carcinoembryonic Antigen and Related Molecules in Normal and Transformed Trophoblast. Placenta 28/2-3:85-96, doi:10.1016/j.placenta.2006.02.002 |
| February 2007 |
Chan CHF et al. (2007): Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family member expression in transgenic mice. PLoS ONE, 2/12: e1353 |
| January 2007 |
Viswanathan A et al. (2007): Functional expression of N-formyl peptide receptors in human bone marrow-derived mesenchymal stem cells. Stem Cells, 25/5:1263-9 |
| December 2006 |
Weinberg AD et al. (2006): Anti-OX40 (CD134) Administration to nonhuman primates: immunostimulatory effects and toxicokinetic study. J Immunother, 29/6: 575-585 |
| November 2006 |
Ellies D et al. (2006): Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res, 21/11:1738-49 |
| October 2006 |
D'Amour K et al (2006): Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol, 24/1: 1392-1401 |
| September 2006 |
Maraqa L. et al (2006): CEACAM: A potential novel predictor of breast cancer recurrence. AACR Meeting Abstracts 2006 : PR-8 |
| September 2006 |
Technology Feature: 'Chain gang' delivers for hard labor. Nature Methods, 3/9: 753-762 |
| May 2006 |
Tsutsumida H et al (2006): RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. Clin Cancer Res, 12: 2976-87 |
| April 2006 |
Krause S et al. (2006): Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor _1. Mol Immunol, 33/11: 1799-1807 |
| April 2006 |
Avadhanula V et al. (2006): Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol, 80/4: 1629-1636 |
| March 2006 |
Nöckel J et al (2006): Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene. BMC Cancer, 6: 57 |
| February 2006 |
Pavoni E et al. (2006): Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein. BMC Cancer, 6: 41 |
| November 2005 |
Klaile E et al (2005): CEACAM1 functionally interacts with filamin A and exerts a dual role in the regulation of cell migration. JCS, 118: 5513-5524 |
| November 2005 |
Bade B et al (2005): Differential expression of the granzymes A, B, K, M and perforin in human peripheral blood lymphocytes. Int. Immunol, 17: 1419-1428 |
| October 2005 |
D'Amour K et al. (2005): Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol, 23: 1534-1541 |
| October 2005 |
Bratke K et al (2005): Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol, 35/9: 2608-2616 |
| October 2005 |
Bade B et al. (2005): Detection of soluble human granzyme K in vitro and in vivo. Eur J Immunol, 35/10:2940-2948 |
| September 2005 |
Roessler et al (2005): Identification of Nicotinamide N-Methyltransferase as a novel serum tumor marker for colorectal cancer. Clin Cancer Res, 11/18: 6550-6558 |
| August 2005 |
Muenzner P et al (2005): CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. J Cell Biol, 170/5: 825-836 |
| May 2005 |
Neckermann S et al (2005): Presentation of the human Hepatitis B surface antigen–loop by the Cpn10 scaffold induces a specific antibody response in mice by genetic immunization. FOCiS annual meeting, Boston, Poster F2.39. |
| April 2005 |
Kalina T et al (2005): Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens. BMC Cancer 5: 38 |
| April 2005 |
Kunii R et al. (2005): Expression of CD13/aminopeptidase N on human gingival fibroblasts and up-regulation upon stimulation with interleukin-4 and interleukin-13. J Periodontal Res, 40/2:138-46 |
| December 2004 |
Nanda A et al. (2004): Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res, 64: 8507-8511 |
| October 2004 |
Kammerer R et al. (2004): The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma. J Pathol, 204/3: 258-267. |
| September 2004 |
Haynes C and BS Schnierle (2004): Retroviral vector targeting through insertion of epidermal growth factor into receptor binding deficient influenza A hemagglutinin results in fusion defective particles. J Virol Methods, 120/2: 189-199 |
| September 2004 |
Kiessling J et al. (2004): Dual targeting of plastid division protein FtsZ to chloroplasts and the cytoplasm. EMBO reports 5 /9: 889-894 |
| August 2004 |
Myrtek D et al. (2004): Expression of interleukin-13 receptor a 1-subunit on peripheral blood eosinophils is regulated by cytokines. Immunology, 112: 597-604 |
| May 2004 |
McCaw S et al. (2004): Engulfment of Neisseria gonorrhoeae: Revealing distinct processes of bacterial entry by individual carcinoembryonic antigen-related cellular adhesion molecule family receptors. Infection and Immunity, 72/5: 2742-2752 |
| January 2004 |
Schmitter T et al. (2004): Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens. J Exp Med, 199/1: 35-46. |
| January 2004 |
Hakansson P et al (2004): Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a). Leukemia 18, 538–547 |
| January 2004 |
Elagoz A et al. (2004): A truncated form of CKb8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor. Br J Pharmacol, 141/1: 37-46. |
| January 2004 |
Bharti S (2004): Novel membrane protein shrew-1 targets to Cadherin-mediated junctions in polarized epithelial cells. Mol Biol Cell, 15: 397-406. |
| December 2003 |
Fahlgren A et al. (2003): Interferon-gamma tempers the expression of carcinoembryonic antigen family molecules in human colon cells: a possible role in innate mucosal defence. Scand J Immunol, 58/6:628-641. |
| November 2003 |
de Jonge MI et al. (2003): Mapping the binding domains on meningococcal Opa proteins for CEACAM1 and CEA receptors. Mol Microbiol, 50/3: 1005 |
| October 2003 |
A shortcut from genomics to drug development. By Jens Lohrmann, Stefan Lang and John Thompson, published in Current Drug Discovery, October 2003. (For reprints please contact Dr. Stefan Lang.) |
| May 2003 |
de Jonge MI et al. (2003): Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitides. Infection and Immunity, 71/5:2331-2340 |
| February 2003 |
Custom-made antibodies produced by genetic immunisation: Applications in drug development, therapy and diagnosis. By Stefan Lang and John Thompson, published in Global Outsourcing Review, Vol. 5, No. 1, Spring 2003. (For reprints please contact Dr. Stefan Lang.) |
| December 2002 |
Genetische Immunisierung zur Antikörperproduktion. Von Stefan Lang und John Thompson, veröffentlicht in transkript, 12/02, 8.Jahrgang. (Text only in German. For reprints please contact Dr. Stefan Lang.) |
| October 2002 |
Bioprocessing - Genetic Immunization for Antibody Production. Tutorial: Genovac's Technological Shortcut From Gene to Antibody. By John Thompson, Ph.D., and Stefan Lang, Ph.D., published in Genetic Engineering News, Vol. 22, No. 17, October 1, 2002 (For reprints please contact Dr. Stefan Lang.) |
| October 2002 |
Klippel S et al. (2002): Biochemical characterisation of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera. Blood, 100/7: 2441-2448 |
| September 2002 |
Genetische Immunisierung - ein hocheffizientes Verfahren zur Antikörper-Herstellung für die medizinische Diagnostik und Therapie. Von Stefan Lang und John Thompson, veröffentlicht in BIOspektrum, Sonderausgabe Proteomics & Drug Development, 8.Jahrgang. (Text only in German. For reprints please contact Dr. Stefan Lang.) |
| August 2002 |
Bioprocessing - Capacity mismatch for production of monoclonals: Development-stage enhancements alleviate bottleneck. By Angelo DePalma, Ph.D., published in Genetic Engineering News, Vol. 22, No. 14, August 2002 (For reprints please contact Dr. Stefan Lang.) |
| April 2002 |
Billker O et al. (2002): Distinct mechanisms of internalisation of Neisseria gonorrhoeae by members of the CEACAM receptor family involving Pac1- and Cdc42-dependent and independent pathways. EMBO J, 21/4: 560-571 |
| March 2002 |
Boulton IC and SD Gray-Owen (2002): Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat Immunol, 3/3:229-236 |
| September 2001 |
Watt SM et al. (2001): Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. Blood, 98/5: 1469-1479 |
| September 2001 |
Richter G. et al. (2001): Tumor necrosis factor -alpha regulates the expression of ICOS ligand on CD34+ progenitor cells during differentiation into antigen presenting cells. J Biol Chem, 276/49: 45686-93 |
| April 2000 |
Temerinac S et al. (2000): Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood, 95/8: 2569-2576 |
| February 2000 |
Schoelzel S et al. (2000): Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol, 156/2: 595-605 |